Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/23907
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hazra, Monica | - |
dc.contributor.author | Uchida, Hiroyuki | - |
dc.contributor.author | Sproule, Beth A. | - |
dc.contributor.author | Remington, Gary | - |
dc.contributor.author | Suzuki, Takefumi | - |
dc.contributor.author | Mamo, David | - |
dc.date.accessioned | 2017-11-16T09:59:05Z | - |
dc.date.available | 2017-11-16T09:59:05Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Hazra, M., Uchida, H., Sproule, B., Remington, G., Suzuki, T., & Mamo, D. C. (2011). Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. Psychiatry and Clinical Neurosciences, 65(7), 676-678. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar//handle/123456789/23907 | - |
dc.description.abstract | The objective was to examine effects of active interventions on physician's prescribing of antipsychotic polypharmacy. Prescriptions for patients with schizophrenia at the Centre for Addiction and Mental Health, Canada were collected in 2006 (n = 648) and 2008 (n = 778). During the intervening period, a pharmacist monitored prescriptions with antipsychotic polypharmacy and contacted corresponding prescribers to provide education on risks of polypharmacy. Moreover, educational sessions on polypharmacy were presented to inpatient and outpatient teams. A three-fold decrease in the prevalence of antipsychotic polypharmacy was observed between 2006 (18.3%) and 2008 (6.6%). Thus, active monitoring of prescriptions with educational interventions could reduce antipsychotic polypharmacy. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | Wiley-Blackwell Publishing Asia | en_GB |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_GB |
dc.subject | Antipsychotic drugs | en_GB |
dc.subject | Pharmacokinetics | en_GB |
dc.subject | Schizophrenia | en_GB |
dc.title | Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.identifier.doi | 10.1111/j.1440-1819.2011.02280.x | - |
dc.publication.title | Psychiatry and Clinical Neurosciences | en_GB |
Appears in Collections: | Scholarly Works - FacM&SPsy |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Hazra_et_al-2011-Psychiatry_and_Clinical_Neurosciences.pdf Restricted Access | 45.87 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.